USD 15.54
(-4.66%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 486.27 Million USD | 39.06% |
2022 | 337.16 Million USD | -3.55% |
2021 | 349.56 Million USD | 14.73% |
2020 | 304.67 Million USD | -15.22% |
2019 | 359.34 Million USD | 0.82% |
2018 | 356.41 Million USD | 4.59% |
2017 | 340.78 Million USD | 5.86% |
2016 | 321.93 Million USD | 3.86% |
2015 | 309.96 Million USD | 2.18% |
2014 | 303.36 Million USD | 1.72% |
2013 | 298.23 Million USD | -20.65% |
2012 | 375.82 Million USD | -14.55% |
2011 | 439.8 Million USD | 1.65% |
2010 | 432.65 Million USD | 6.25% |
2009 | 407.18 Million USD | 10.75% |
2008 | 367.66 Million USD | 1.76% |
2007 | 361.29 Million USD | 32.96% |
2006 | 271.73 Million USD | 18.39% |
2005 | 229.51 Million USD | 10.63% |
2004 | 207.46 Million USD | 35.94% |
2003 | 152.61 Million USD | 14.94% |
2002 | 132.77 Million USD | 11.2% |
2001 | 119.4 Million USD | 15.51% |
2000 | 103.37 Million USD | 13.47% |
1999 | 91.09 Million USD | 17.39% |
1998 | 77.6 Million USD | 15.3% |
1997 | 67.3 Million USD | 19.96% |
1996 | 56.1 Million USD | 63.56% |
1995 | 34.3 Million USD | 27.51% |
1994 | 26.9 Million USD | 19.56% |
1993 | 22.5 Million USD | 12.5% |
1992 | 20 Million USD | -4.31% |
1991 | 20.9 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 130.43 Million USD | 6.03% |
2024 Q1 | 123.01 Million USD | -7.06% |
2023 Q1 | 110.32 Million USD | 23.72% |
2023 FY | 468.86 Million USD | 39.06% |
2023 Q2 | 119.55 Million USD | 8.36% |
2023 Q3 | 119.76 Million USD | 0.18% |
2023 Q4 | 132.35 Million USD | 10.52% |
2022 Q1 | 78.1 Million USD | -14.93% |
2022 Q3 | 83.42 Million USD | -3.52% |
2022 FY | 337.16 Million USD | -3.55% |
2022 Q2 | 86.47 Million USD | 10.72% |
2022 Q4 | 89.17 Million USD | 6.9% |
2021 FY | 349.56 Million USD | 14.73% |
2021 Q1 | 79.67 Million USD | -10.02% |
2021 Q2 | 93.95 Million USD | 17.92% |
2021 Q3 | 84.12 Million USD | -10.47% |
2021 Q4 | 91.81 Million USD | 9.14% |
2020 Q3 | 84.74 Million USD | 69.59% |
2020 Q1 | 81.41 Million USD | -14.57% |
2020 Q4 | 88.54 Million USD | 4.49% |
2020 FY | 304.67 Million USD | -15.22% |
2020 Q2 | 49.96 Million USD | -38.62% |
2019 Q1 | 85.4 Million USD | -10.53% |
2019 Q2 | 90.03 Million USD | 5.43% |
2019 Q3 | 88.6 Million USD | -1.59% |
2019 Q4 | 95.3 Million USD | 7.56% |
2019 FY | 359.34 Million USD | 0.82% |
2018 Q4 | 95.45 Million USD | 8.85% |
2018 FY | 356.41 Million USD | 4.59% |
2018 Q2 | 88.71 Million USD | 4.91% |
2018 Q3 | 87.68 Million USD | -1.15% |
2018 Q1 | 84.56 Million USD | -9.4% |
2017 Q1 | 80.15 Million USD | -5.94% |
2017 Q4 | 93.33 Million USD | 14.48% |
2017 Q3 | 81.53 Million USD | -4.94% |
2017 FY | 340.78 Million USD | 5.86% |
2017 Q2 | 85.76 Million USD | 7.0% |
2016 FY | 321.93 Million USD | 3.86% |
2016 Q4 | 85.21 Million USD | 8.4% |
2016 Q1 | 76.54 Million USD | -8.01% |
2016 Q3 | 78.61 Million USD | -3.61% |
2016 Q2 | 81.56 Million USD | 6.55% |
2015 Q3 | 77.28 Million USD | -2.22% |
2015 Q1 | 70.42 Million USD | -10.66% |
2015 FY | 309.96 Million USD | 2.18% |
2015 Q2 | 79.04 Million USD | 12.24% |
2015 Q4 | 83.21 Million USD | 7.67% |
2014 Q1 | 78.71 Million USD | 6.91% |
2014 Q4 | 78.82 Million USD | 4.1% |
2014 Q2 | 75.57 Million USD | -3.99% |
2014 FY | 303.36 Million USD | 1.72% |
2014 Q3 | 75.72 Million USD | 0.21% |
2013 Q3 | 68.81 Million USD | -11.81% |
2013 FY | 298.23 Million USD | -20.65% |
2013 Q4 | 73.62 Million USD | 6.99% |
2013 Q2 | 78.03 Million USD | 0.62% |
2013 Q1 | 77.55 Million USD | -17.08% |
2012 Q4 | 93.53 Million USD | 1.25% |
2012 FY | 375.82 Million USD | -14.55% |
2012 Q1 | 110.25 Million USD | -5.29% |
2012 Q2 | 95.81 Million USD | -13.1% |
2012 Q3 | 92.37 Million USD | -3.59% |
2011 FY | 439.8 Million USD | 1.65% |
2011 Q4 | 116.42 Million USD | 7.09% |
2011 Q2 | 108.85 Million USD | 2.89% |
2011 Q3 | 108.71 Million USD | -0.13% |
2011 Q1 | 105.8 Million USD | -4.79% |
2010 FY | 432.65 Million USD | 6.25% |
2010 Q4 | 111.12 Million USD | 4.21% |
2010 Q1 | 106.12 Million USD | -1.06% |
2010 Q2 | 108.75 Million USD | 2.48% |
2010 Q3 | 106.64 Million USD | -1.95% |
2009 Q4 | 107.26 Million USD | 4.03% |
2009 Q3 | 103.11 Million USD | 2.46% |
2009 Q1 | 96.16 Million USD | -1.44% |
2009 Q2 | 100.63 Million USD | 4.65% |
2009 FY | 407.18 Million USD | 10.75% |
2008 Q4 | 97.57 Million USD | 20.01% |
2008 Q1 | 93.79 Million USD | -0.59% |
2008 Q2 | 94.99 Million USD | 1.28% |
2008 FY | 367.66 Million USD | 1.76% |
2008 Q3 | 81.3 Million USD | -14.41% |
2007 FY | 361.29 Million USD | 32.96% |
2007 Q4 | 94.34 Million USD | 4.39% |
2007 Q1 | 86.23 Million USD | 0.06% |
2007 Q3 | 90.37 Million USD | 0.06% |
2007 Q2 | 90.32 Million USD | 4.75% |
2006 Q2 | 63.53 Million USD | 6.5% |
2006 FY | 271.73 Million USD | 18.39% |
2006 Q4 | 86.18 Million USD | 38.2% |
2006 Q1 | 59.65 Million USD | 2.26% |
2006 Q3 | 62.36 Million USD | -1.85% |
2005 Q2 | 58.76 Million USD | 3.47% |
2005 FY | 229.51 Million USD | 10.63% |
2005 Q4 | 58.34 Million USD | 4.89% |
2005 Q3 | 55.61 Million USD | -5.35% |
2005 Q1 | 56.79 Million USD | 6.62% |
2004 Q1 | 51.19 Million USD | 28.97% |
2004 Q3 | 51.9 Million USD | 1.58% |
2004 Q2 | 51.09 Million USD | -0.19% |
2004 Q4 | 53.26 Million USD | 2.62% |
2004 FY | 207.46 Million USD | 35.94% |
2003 Q3 | 38.77 Million USD | 0.56% |
2003 FY | 152.61 Million USD | 14.94% |
2003 Q1 | 35.59 Million USD | 5.36% |
2003 Q2 | 38.55 Million USD | 8.32% |
2003 Q4 | 39.69 Million USD | 2.38% |
2002 Q3 | 33.56 Million USD | -0.52% |
2002 Q1 | 31.68 Million USD | -26.31% |
2002 Q2 | 33.74 Million USD | 6.49% |
2002 FY | 132.77 Million USD | 11.2% |
2002 Q4 | 33.78 Million USD | 0.66% |
2001 Q4 | 42.99 Million USD | 7.07% |
2001 Q3 | 40.15 Million USD | 35.25% |
2001 Q1 | 28.38 Million USD | -11.5% |
2001 Q2 | 29.69 Million USD | 4.61% |
2001 FY | 119.4 Million USD | 15.51% |
2000 Q1 | 24.02 Million USD | -8.63% |
2000 Q4 | 32.07 Million USD | 37.21% |
2000 Q3 | 23.37 Million USD | -2.21% |
2000 FY | 103.37 Million USD | 13.47% |
2000 Q2 | 23.9 Million USD | -0.53% |
1999 FY | 91.09 Million USD | 17.39% |
1999 Q2 | 22 Million USD | 3.29% |
1999 Q4 | 26.29 Million USD | 22.31% |
1999 Q3 | 21.5 Million USD | -2.27% |
1999 Q1 | 21.3 Million USD | -21.69% |
1998 Q3 | 26.4 Million USD | 3.53% |
1998 FY | 77.6 Million USD | 15.3% |
1998 Q4 | 27.2 Million USD | 3.03% |
1998 Q1 | 25 Million USD | 3.31% |
1998 Q2 | 25.5 Million USD | 2.0% |
1997 Q2 | 22.4 Million USD | 8.74% |
1997 FY | 67.3 Million USD | 19.96% |
1997 Q4 | 24.2 Million USD | 6.14% |
1997 Q3 | 22.8 Million USD | 1.79% |
1997 Q1 | 20.6 Million USD | 3.0% |
1996 Q3 | 19.2 Million USD | 1.05% |
1996 Q4 | 20 Million USD | 4.17% |
1996 Q2 | 19 Million USD | 0.0% |
1996 FY | 56.1 Million USD | 63.56% |
1996 Q1 | 19 Million USD | 13.1% |
1995 FY | 34.3 Million USD | 27.51% |
1995 Q4 | 16.8 Million USD | 35.48% |
1995 Q1 | 7.5 Million USD | -31.82% |
1995 Q2 | 11.6 Million USD | 54.67% |
1995 Q3 | 12.4 Million USD | 6.9% |
1994 Q4 | 11 Million USD | 13.4% |
1994 Q2 | 6.5 Million USD | -30.11% |
1994 Q1 | 9.3 Million USD | 8.14% |
1994 FY | 26.9 Million USD | 19.56% |
1994 Q3 | 9.7 Million USD | 49.23% |
1993 Q4 | 8.6 Million USD | 19.44% |
1993 FY | 22.5 Million USD | 12.5% |
1993 Q3 | 7.2 Million USD | -6.49% |
1993 Q2 | 7.7 Million USD | -1.28% |
1993 Q1 | 7.8 Million USD | 6.85% |
1992 Q1 | 7.1 Million USD | 33.96% |
1992 FY | 20 Million USD | -4.31% |
1992 Q4 | 7.3 Million USD | 5.8% |
1992 Q3 | 6.9 Million USD | 4.55% |
1992 Q2 | 6.6 Million USD | -7.04% |
1991 Q3 | 5.2 Million USD | 0.0% |
1991 FY | 20.9 Million USD | 0.0% |
1991 Q1 | 5.2 Million USD | 0.0% |
1991 Q2 | 5.2 Million USD | 0.0% |
1991 Q4 | 5.3 Million USD | 1.92% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acutus Medical, Inc. | -3.13 Million USD | 15601.211% |
Cerus Corporation | 86.4 Million USD | -462.816% |
OrthoPediatrics Corp. | 111.25 Million USD | -337.088% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | -65654.686% |
Talis Biomedical Corporation | 371 Thousand USD | -130970.889% |
Vivos Therapeutics, Inc. | 8.27 Million USD | -5779.253% |
Inogen, Inc. | 126.69 Million USD | -283.802% |
Spectral AI, Inc. | 7.88 Million USD | -6070.977% |
Nano-X Imaging Ltd. | -6.59 Million USD | 7476.714% |
CVRx, Inc. | 33.03 Million USD | -1371.815% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
Helius Medical Technologies, Inc. | 61 Thousand USD | -797068.852% |
Venus Concept Inc. | 52.16 Million USD | -832.147% |
Accelerate Diagnostics, Inc. | 2.55 Million USD | -18969.529% |
Bioventus Inc. | 328.19 Million USD | -48.167% |
BrainsWay Ltd. | 23.09 Million USD | -2005.898% |
Envoy Medical, Inc. | -473 Thousand USD | 102906.131% |
electroCore, Inc. | 13.22 Million USD | -3576.644% |
IceCure Medical Ltd | 1.3 Million USD | -37305.615% |
Lucid Diagnostics Inc. | -6.05 Million USD | 8137.57% |
Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 1027379.449% |
MaxCyte, Inc. | 36.54 Million USD | -1230.578% |
NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -106418.049% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -571582.342% |
PAVmed Inc | -3.96 Million USD | 12354.864% |
Rapid Micro Biosystems, Inc. | -5.48 Million USD | 8965.506% |
RxSight, Inc. | 53.76 Million USD | -804.442% |
Sight Sciences, Inc. | 69.17 Million USD | -602.961% |
SI-BONE, Inc. | 109.42 Million USD | -344.41% |
TELA Bio, Inc. | 40.11 Million USD | -1112.288% |
TriSalus Life Sciences, Inc. | 15.9 Million USD | -2957.167% |
Treace Medical Concepts, Inc. | 151.93 Million USD | -220.049% |
LivaNova PLC | 771.25 Million USD | 36.95% |
908 Devices Inc. | 25.32 Million USD | -1820.358% |
Alphatec Holdings, Inc. | 310.2 Million USD | -56.76% |
Nemaura Medical Inc. | -1.47 Million USD | 33036.578% |
NeuroPace, Inc. | 48.12 Million USD | -910.5% |
LENSAR, Inc. | 21.1 Million USD | -2203.847% |
Apyx Medical Corporation | 14.12 Million USD | -3343.372% |
Cutera, Inc. | 41.49 Million USD | -1071.912% |
STRATA Skin Sciences, Inc. | 18.46 Million USD | -2534.056% |
BioSig Technologies, Inc. | 18 Thousand USD | -2701416.667% |
Anika Therapeutics, Inc. | 103.08 Million USD | -371.707% |
ClearPoint Neuro, Inc. | 13.61 Million USD | -3471.86% |
Integra LifeSciences Holdings Corporation | 888.39 Million USD | 45.264% |
Axonics, Inc. | 274.55 Million USD | -77.114% |
Outset Medical, Inc. | 29 Million USD | -1576.803% |
IRIDEX Corporation | 21.8 Million USD | -2129.894% |
PROCEPT BioRobotics Corporation | 71.04 Million USD | -584.419% |
IRadimed Corporation | 50.15 Million USD | -869.477% |
Tivic Health Systems, Inc. | 287 Thousand USD | -169333.101% |
INVO Bioscience, Inc. | 1.08 Million USD | -44670.83% |
Telesis Bio, Inc. | 16.95 Million USD | -2768.867% |
Viemed Healthcare, Inc. | 112.78 Million USD | -331.158% |
Varex Imaging Corporation | 256.9 Million USD | -89.285% |
Quipt Home Medical Corp. | 163.84 Million USD | -196.788% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 119871.675% |
Pulmonx Corporation | 50.75 Million USD | -858.136% |
Dynatronics Corporation | 7.63 Million USD | -6269.016% |
Modular Medical, Inc. | -768 Thousand USD | 63416.797% |
ReShape Lifesciences Inc. | 5.54 Million USD | -8664.834% |
Semler Scientific, Inc. | 61.2 Million USD | -694.564% |
InMode Ltd. | 411.34 Million USD | -18.217% |
Bruker Corporation | 1.51 Billion USD | 67.941% |
Cytosorbents Corporation | 22.39 Million USD | -2071.635% |
DexCom, Inc. | 2.28 Billion USD | 78.755% |
Align Technology, Inc. | 2.71 Billion USD | 82.114% |
Viveve Medical, Inc. | 620 Thousand USD | -78331.129% |
ZimVie Inc. | 290.38 Million USD | -67.459% |
Movano Inc. | -158 Thousand USD | 307867.722% |
Cytek Biosciences, Inc. | 109.42 Million USD | -344.385% |
Nexalin Technology, Inc. | 85.06 Thousand USD | -571582.342% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 367.69 Million USD | -32.251% |
Profound Medical Corp. | 4.51 Million USD | -10672.502% |
Insulet Corporation | 1.15 Billion USD | 58.076% |
enVVeno Medical Corporation | -546 Thousand USD | 89160.989% |
Surmodics, Inc. | 93.05 Million USD | -422.582% |
iCAD, Inc. | 14.53 Million USD | -3245.301% |
Nuwellis, Inc. | 4.98 Million USD | -9658.639% |
Biotricity, Inc. | 8.35 Million USD | -5719.251% |
iRhythm Technologies, Inc. | 331.8 Million USD | -46.553% |
Aethlon Medical, Inc. | -359.05 Thousand USD | 135530.586% |
InspireMD, Inc. | 1.8 Million USD | -26810.515% |
PAVmed Inc. | -3.96 Million USD | 12354.864% |
BIOLASE, Inc. | 16.72 Million USD | -2807.636% |
Beyond Air, Inc. | -1.3 Million USD | 37305.279% |
FONAR Corporation | 45.14 Million USD | -977.254% |
AxoGen, Inc. | 127.87 Million USD | -280.275% |
Vivani Medical, Inc. | -357 Thousand USD | 136310.924% |
Tactile Systems Technology, Inc. | 195.13 Million USD | -149.201% |
Inari Medical, Inc. | 434.56 Million USD | -11.899% |
UFP Technologies, Inc. | 112.22 Million USD | -333.302% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 12.51 Thousand USD | -3884179.895% |
Tenon Medical, Inc. | 1.24 Million USD | -39083.965% |
Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 600437.037% |
Co-Diagnostics, Inc. | 2.62 Million USD | -18409.955% |
AdaptHealth Corp. | 479.56 Million USD | -1.399% |
Sintx Technologies, Inc. | 1.84 Million USD | -26284.862% |
NanoVibronix, Inc. | 1.53 Million USD | -31537.801% |
Quanterix Corporation | 70.64 Million USD | -588.323% |
Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 119871.675% |
Sensus Healthcare, Inc. | 14.06 Million USD | -3358.556% |
Pacific Biosciences of California, Inc. | 52.78 Million USD | -821.321% |
TransMedics Group, Inc. | 154.09 Million USD | -215.571% |
ReWalk Robotics Ltd. | 4.45 Million USD | -10820.121% |
NeuroMetrix, Inc. | 3.94 Million USD | -12218.777% |
Hyperfine, Inc. | 4.75 Million USD | -10122.262% |
Establishment Labs Holdings Inc. | 106.97 Million USD | -354.558% |
Biomerica, Inc. | 611 Thousand USD | -79486.416% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 41.68 Million USD | -1066.475% |
Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 62366.456% |
Silk Road Medical, Inc | 127.08 Million USD | -282.633% |